| SpectraBase Spectrum ID |
GLUuDxbVXbA |
| Name |
Antazoline |
| CAS Registry Number |
91-75-8 |
| Classification |
Pharmaceutical drug, anti-allergic |
| Comments |
Spectrum verified by crosschecking against external libraries (one reference spectrum with similarity >= 99% found) |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
265.157897624 u |
| Formula |
C17H19N3 |
| InChI |
InChI=1S/C17H19N3/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16/h1-10H,11-14H2,(H,18,19) |
| InChIKey |
REYFJDPCWQRWAA-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
265.360 g/mol |
| Nominal Mass |
265 u |
| Quality |
812 |
| Retention Index |
2251 |
| SMILES |
C=1(N(CC=2NCCN2)CC=2C=CC=CC2)C=CC=CC1 |
| SPLASH |
splash10-001i-9200000000-034b0739ac33969f87b3 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Antasohn
Imidaminum
N-Benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline |
| Technique |
GC/MS |
| Wiley ID |
DD2024_012031 |
